Regulatory Affairs for Biotechnology
BIOENGR X 431.4
This course introduces and reviews the role of Regulatory Affairs (RA) in the biotechnology industry.
What you can learn.
- Understand the rules and regulations related to getting a medical product approved in the U.S. and Europe
- Learn how to get medical products quickly to market in the US and Europe that are safe and efficacious
- Study an effective strategy to properly approach, deal, plan, and agree with domestic and foreign regulatory bodies
About this course:
This course introduces and reviews the role of Regulatory Affairs (RA) in the biotechnology industry. The RA environment embraces the regulations and standards governing product development from its infancy through post-approval monitoring. In today's regulatory environment, products may be classified as biologics, drugs, medical devices, or combination (of the former) products. In most worldwide countries, each type of product is regulated by a different RA authority and often has its own distinct regulations. This course primarily focuses on the U.S. and the European Union (EU) regulatory processes (although other countries such as Canada and Japan are also briefly reviewed). Course topics include: RA history, the various regulatory agencies, accessing RA information, drug submissions, biological submissions, Quality System Regulations (QSR), Good Laboratory Practices (GLP), Good Clinical Practice (GCP), Good Manufacturing Practice (GMP), and EU & FDA inspections. It will also include strategies to get products to market quickly and in a safe and efficacious fashion.